Wang SC - Search Results

1

IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion.

Chan LC, Li CW, Xia W, Hsu JM, Lee HH, Cha JH, Wang HL, Yang WH, Yen EY, Chang WC, Zha Z, Lim SO, Lai YJ, Liu C, Liu J, Dong Q, Yang Y, Sun L, Wei Y, Nie L, Hsu JL, Li H, Ye Q, Hassan MM, Amin HM, Kaseb AO, Lin X, Wang SC, Hung MC. Chan LC, et al. Among authors: wang sc, wang hl. J Clin Invest. 2019 Jul 15;129(8):3324-3338. doi: 10.1172/JCI126022. eCollection 2019 Jul 15. J Clin Invest. 2019. PMID: 31305264 Free PMC article.

2

Systemic tumor suppression by the proapoptotic gene bik.

Zou Y, Peng H, Zhou B, Wen Y, Wang SC, Tsai EM, Hung MC. Zou Y, et al. Among authors: wang sc. Cancer Res. 2002 Jan 1;62(1):8-12. Cancer Res. 2002. PMID: 11782349

3

Inhibition of cancer cell growth by BRCA2.

Wang SC, Shao R, Pao AY, Zhang S, Hung MC, Su LK. Wang SC, et al. Cancer Res. 2002 Mar 1;62(5):1311-4. Cancer Res. 2002. PMID: 11888897

4

External control of Her2 expression and cancer cell growth by targeting a Ras-linked coactivator.

Asada S, Choi Y, Yamada M, Wang SC, Hung MC, Qin J, Uesugi M. Asada S, et al. Among authors: wang sc. Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12747-52. doi: 10.1073/pnas.202162199. Epub 2002 Sep 19. Proc Natl Acad Sci U S A. 2002. PMID: 12242338 Free PMC article.

5

beta-catenin nuclear localization is associated with grade in ovarian serous carcinoma.

Lee CM, Shvartsman H, Deavers MT, Wang SC, Xia W, Schmandt R, Bodurka DC, Atkinson EN, Malpica A, Gershenson DM, Hung MC, Lu KH. Lee CM, et al. Among authors: wang sc. Gynecol Oncol. 2003 Mar;88(3):363-8. doi: 10.1016/s0090-8258(02)00015-x. Gynecol Oncol. 2003. PMID: 12648588

6

A delayed chemically induced tumorigenesis in Brca2 mutant mice.

Yan DH, Wen Y, Su LK, Xia W, Wang SC, Zhang S, Gan L, Lee DF, Spohn B, Frey JA, Hortobagyi GN, Hung MC. Yan DH, et al. Among authors: wang sc. Oncogene. 2004 Mar 11;23(10):1896-901. doi: 10.1038/sj.onc.1207314. Oncogene. 2004. PMID: 14981540

7

Selective activation of ceruloplasmin promoter in ovarian tumors: potential use for gene therapy.

Lee CM, Lo HW, Shao RP, Wang SC, Xia W, Gershenson DM, Hung MC. Lee CM, et al. Among authors: wang sc. Cancer Res. 2004 Mar 1;64(5):1788-93. doi: 10.1158/0008-5472.can-03-2551. Cancer Res. 2004. PMID: 14996741

8

Upregulation of IKKalpha/IKKbeta by integrin-linked kinase is required for HER2/neu-induced NF-kappaB antiapoptotic pathway.

Makino K, Day CP, Wang SC, Li YM, Hung MC. Makino K, et al. Among authors: wang sc. Oncogene. 2004 May 6;23(21):3883-7. doi: 10.1038/sj.onc.1207485. Oncogene. 2004. PMID: 15021910

9

Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2.

Wang SC, Lien HC, Xia W, Chen IF, Lo HW, Wang Z, Ali-Seyed M, Lee DF, Bartholomeusz G, Ou-Yang F, Giri DK, Hung MC. Wang SC, et al. Among authors: wang z. Cancer Cell. 2004 Sep;6(3):251-61. doi: 10.1016/j.ccr.2004.07.012. Cancer Cell. 2004. PMID: 15380516 Free article.

10

Finding the bEST routes to cancer.

Wang SC, Hung MC. Wang SC, et al. Cancer Biol Ther. 2004 Nov;3(11):1090-1. doi: 10.4161/cbt.3.11.1403. Epub 2004 Nov 15. Cancer Biol Ther. 2004. PMID: 15640624 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,200 results

Search Page